NEUROPACE INC. - COMMON STOCK

NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

12 Nov 2024 16:05:01 By Nasdaq GlobeNewswire

NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy

04 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024

22 Oct 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Continues to Strengthen Management Team

16 Oct 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Strengthens Management Team with Two Key Appointments

04 Sep 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences

27 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Participate in Upcoming Healthcare Conferences in September

22 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

13 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Report Second Quarter 2024 Financial Results on August 13, 2024

23 Jul 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Participate in Two Healthcare Conferences in May

14 May 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update

08 May 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024

17 Apr 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Present at the Needham 23rd Annual Healthcare Conference

27 Mar 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million

05 Mar 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

15 Feb 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates

08 Jan 2024 07:03:00 By Nasdaq GlobeNewswire

NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study

21 Dec 2023 07:07:00 By Nasdaq GlobeNewswire

NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference

19 Dec 2023 16:30:00 By Nasdaq GlobeNewswire

NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration

04 Dec 2023 17:07:00 By Nasdaq GlobeNewswire

NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting

01 Dec 2023 08:00:00 By Nasdaq GlobeNewswire